A reagent composition, a kit and a method for detecting mycoplasma contamination in a cell culture process

The reagent compositions of MgCO3·5H2O and MgSO4 use the fluorescence reaction of ATP, and the problem of complex and time-consuming detection of Mycoplasma contamination in the prior art is solved, and the rapid and accurate detection efficiency is achieved. It is suitable for cell culture supernatant samples. .

CN115820792BActive Publication Date: 2024-11-08JIANGSU KEYGEN BIOTECH CORP LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211638342.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-12-19
Publication Date
2024-11-08
Estimated Expiration
2042-12-19

AI Technical Summary

Technical Problem

The existing methods for detecting Mycoplasma contamination are complex in operation, low in sensitivity and long in time, making it difficult to achieve fast, accurate and low-cost detection.

Method used

Using a reagent composition containing MgCO3·5H2O and MgSO4, the presence of mycoplasma was detected by fluorescence reaction of ATP, and the luminescence reaction catalyzed by D-fluorescein potassium salt and firefly luciferase was calculated before and after the addition of component I and component II. Fluorescence ratio is used to determine whether the cells are contaminated by Mycoplasma.

Benefits of technology

It realizes rapid, accurate and simple operation of detecting Mycoplasma contamination during cell culture. It is suitable for the detection of cell culture supernatant samples, improving detection efficiency and practicality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115820792B_ABST
    Figure CN115820792B_ABST
Patent Text Reader

Abstract

The present invention discloses a reagent composition for detecting mycoplasma contamination in a cell culture process, comprising component A and component B, wherein component A comprises Tricine, MgSO4, (MgCO3)4Mg(OH)2·5H2O, firefly luciferase, D-luciferin potassium salt, Triton X-100, BSA, EDTA, DTT; component B comprises Tricine, MgSO4, EDTA, DTT, ADP. The reagent composition proposed in the present invention can detect mycoplasma contamination in a cell culture process, can improve detection efficiency, is simple to operate, has strong practicality, can be applied to mycoplasma detection of cell culture supernatant samples, and has accurate detection results.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of bioluminescence detection, and specifically relates to a reagent composition, a kit and a method for detecting mycoplasma contamination in a cell culture process. Background Art

[0002] Mycoplasma is a type of minimal prokaryotic cell-type microorganism that has no cell wall, is highly polymorphic, can pass through a bacterial filter, and can be cultured and proliferated in artificial culture media. It is 0.1 to 0.8 μm in size. Because it can form filamentous and branched shapes, it is called mycoplasma. Many mycoplasmas rely on the host to provide nutrition due to their limited biosynthetic capacity, so they are usually adsorbed or scattered on the cell surface and between cells. The contamination of cell culture by mycoplasma is a very common problem. Since Robinson et al. first isolated mycoplasma from Hela cell culture in 1956, reports on mycoplasma-contaminated cells have been common at home and abroad. The sources of mycoplasma that contaminate cells are multifaceted. The working environment, experimental equipment, culture medium and the operator themselves are all possible sources of contamination. In fact, different levels of mycoplasma contamination may occur according to the different influences of the laboratory environment. Mycoplasma contamination seriously affects the purity of cell culture and its biological products, so the detection of mycoplasma contamination is very important.

[0003] Common methods for detecting mycoplasma contamination include isolation and culture, probe method, PCR method, DNA fluorescent staining method, ELISA and special biochemical detection. Most of the above detection methods have relatively complicated operation steps, low sensitivity or long time required. Therefore, it is of great application prospect to develop a detection method that is simple and fast to operate, low in cost and high in accuracy. Summary of the invention

[0004] Purpose of the invention: The purpose of the present invention is to provide a reagent composition for detecting mycoplasma contamination in a cell culture process. The use of the reagent combination to detect mycoplasma contamination in a cell culture process is simple, fast and accurate.

[0005] Another object of the present invention is to provide a kit for detecting mycoplasma contamination in a cell culture process. The kit can be used to detect mycoplasma contamination in a cell culture process, which can improve detection efficiency, is simple to operate, and has strong practicality, and can be applied to mycoplasma detection of cell culture supernatant samples.

[0006] Another object of the present invention is to provide a method for detecting mycoplasma contamination in a cell culture process. The method is simple to operate, has higher detection efficiency, and has accurate detection results.

[0007] To achieve the above object, the present invention discloses a reagent composition for detecting mycoplasma contamination in a cell culture process, characterized in that it comprises component I and component II, wherein component I comprises the following components:

[0008]

[0009] Among them, MgCO3)4Mg(OH)2·5H2O causes a slight alkaline reaction in water, providing an alkaline environment for the entire reaction; MgSO4 is used to provide a Mg2+ ion environment.

[0010] In a preferred embodiment, the component I comprises the following components:

[0011]

[0012]

[0013] Component II comprises the following components:

[0014]

[0015] The present invention further provides a kit for detecting mycoplasma contamination in a cell culture process, which comprises the above reagent composition.

[0016] Wherein, the detection sample of the kit is cell culture supernatant.

[0017] The present invention further proposes a method for detecting mycoplasma contamination in a cell culture process using the above reagent composition, comprising the following steps:

[0018] (1) Add the sample to be tested into a black 96-well test plate;

[0019] (2) Add component I and pipette evenly to avoid bubbles. Detect the fluorescence value after 5-10 minutes and record it as A.

[0020] (3) Add component II and pipette evenly to avoid bubbles. Detect the fluorescence value after 5-10 minutes and record it as B.

[0021] (4) Determine whether there is mycoplasma contamination by calculating the ratio of B to A; when B / A>1, it indicates that the cells are contaminated with mycoplasma; when B / A<1, it indicates that the cells are not contaminated with mycoplasma; when the B / A value is within the range of 1±0.1, in order to ensure the accuracy of the results, the cells should be cultured for another 48 hours and the experiment should be repeated.

[0022] Beneficial effects: Compared with the prior art, the reagent composition proposed by the present invention can detect mycoplasma contamination in the cell culture process, can improve the detection efficiency, is simple to operate, has strong practicality, can be applied to mycoplasma detection of cell culture supernatant samples, and the detection results are accurate. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 The schematic diagram is a principle diagram of the kit of the present invention for detecting mycoplasma. DETAILED DESCRIPTION

[0024] The following examples further illustrate the present invention, but should not be construed as limiting the present invention.

[0025] Unless otherwise specified, the experimental techniques used in the present invention are conventional techniques well known to those skilled in the art.

[0026] The control kit used in the present invention is Myco-Lumi TM The luminescence mycoplasma detection kit was purchased from Beyotime Company; D-Luciferin potassium salt was purchased from Beyotime Company; firefly luciferase (QuantiLum Recombinant Luciferase) was purchased from Promega Company; and the remaining reagents were purchased from Sinopharm Company.

[0027] The present invention utilizes the enzyme unique to mycoplasma to convert ADP into ATP and detects through the luminescent reaction catalyzed by ATP-dependent luciferase, and determines whether the sample is contaminated with mycoplasma by comparing the change in ATP amount before and after the addition of the detection reagent. The operation is simple and fast, the cost is low, and the accuracy is high. The principle of the kit of the present invention for detecting mycoplasma is as follows Figure 1 As shown. This kit uses the activity of ATP synthase unique to mycoplasma to synthesize ATP after adding ADP to the sample. Using D-luciferin potassium salt as a substrate and Mg2+ as a catalyst, ATP is detected through a luminescent reaction catalyzed by luciferase, and finally the change in ATP amount is compared to determine whether the sample is contaminated with mycoplasma. The first step is to add detection reagent I to the sample, let it stand for 5-10 minutes, and set the reading value to A after the reaction is completed; the second step is to add mycoplasma detection reagent II, let it stand for 5-10 minutes, and the reading value is B. If the sample is contaminated with mycoplasma, the mycoplasma-specific enzyme can convert the ADP in reagent B into ATP, and the ATP content is the sum of the background ATP amount and the newly generated ATP amount catalyzed by the mycoplasma-specific enzyme. The ratio of B to A is calculated to determine whether there is mycoplasma contamination. The judgment criteria are: B / A>1, indicating mycoplasma contamination; B / A<1, indicating no mycoplasma contamination; the ratio is between 1±0.1, it is recommended to continue culturing for 24-48 hours and then retest.

[0028] Example 1: Fluorescence detection of component I.

[0029] The A component that does not contain D-luciferin potassium salt and firefly luciferase is called an incomplete A component, which specifically includes the following steps:

[0030] (1) Prepare incomplete component I, which specifically includes: 30 mM Tricine, 2 mM MgSO4, 2 mM (MgCO3)4Mg(OH)2·5H2O, 1% Triton X-100, 2 mg / ml BSA, 0.1 mM EDTA, and 33.3 mM DTT.

[0031] (2) 18 wells were selected from a black 96-well assay plate and divided into 6 groups, each with 3 replicate wells. 50 μl of incomplete component I was added to each well. ATP, 0.03 mM firefly luciferase, 157 mM D-luciferin potassium salt, 0.03 mM firefly luciferase + 157 mM D-luciferin potassium salt, and 0.5 mM ATP + 0.03 mM firefly luciferase + 157 mM D-luciferin potassium salt were added to 5 of the groups, respectively, and the mixture was mixed and placed at 20-25°C for 10 minutes. Then, chemiluminescence detection was performed using a multifunctional microplate reader, and the reading value was A. The measurement was repeated three times, and the results were A1, A2, and A3, respectively. The results are shown in Table 1.

[0032] Table 1. Fluorescence detection results of component A

[0033]

[0034] The results showed that component I could excite fluorescence in the presence of ATP.

[0035] Example 2: Fluorescence detection of component II.

[0036] The specific steps include:

[0037] (1) Prepare component II, which includes: 30 mM Tricine, 2 mM MgSO4, 0.1 mM EDTA, 33.3 mM DTT, and 0.58 mM ADP.

[0038] (2) Select 3 wells in a black 96-well test plate, add 50 μl of component II to each well, and place at 20-25°C for 5 minutes. Then use a multifunctional microplate reader to perform chemiluminescence detection, and the reading value is B. The results are shown in Table 2.

[0039] Table 2. Fluorescence detection results of component B

[0040] name B1 B2 B3 Component II 3.025 1.879 2.641

[0041] The results show that component B itself does not excite fluorescence.

[0042] Example 3: Time-gradient fluorescence detection of component I.

[0043] The specific steps include:

[0044] (1) Prepare component I, which specifically includes: 30 mM Tricine, 2 mM MgSO4, 2 mM (MgCO3)4Mg(OH)2·5H2O, 1% Triton X-100, 2 mg / ml BSA, 0.1 mM EDTA, 33.3 mM DTT, 0.05 mM firefly luciferase, and 157 mM D-luciferin potassium salt.

[0045] (2) 21 wells were selected from a black 96-well test plate and divided into 7 groups, with 3 replicates in each group. 50 μl of component A was added to each well. Then, the same amount of ATP was added to each well. The wells were mixed and placed at 20-25°C. A group was selected at 0, 5, 10, 15, 20, 25 and 30 minutes, and chemiluminescence detection was performed using a multifunctional microplate reader. The reading value was A. The results are shown in Table 3.

[0046] Table 3. Time gradient fluorescence detection results of component A

[0047] name A1 A2 A3 Component I+ATP+0min 7200 6900 7100 Component I+ATP+5min 11000 13000 12000 Component I+ATP+10min 29000 31000 33000 Component I+ATP+15min 37000 44000 41000 Component I+ATP+20min 33000 42000 35000 Component I+ATP+25min 19000 22000 23000 Component I+ATP+30min 13000 14000 17000

[0048] The results showed that in the presence of a certain amount of ATP, the fluorescence excitation intensity of component I first increased and then decreased as the reaction time prolonged. The fluorescence excitation intensity was the highest at 15 minutes of reaction.

[0049] Example 4: Time-gradient fluorescence detection of component B.

[0050] The specific steps include:

[0051] (1) Prepare component A I, which specifically includes: 30 mM Tricine, 2 mM MgSO4, 2 mM (MgCO3)4Mg(OH)2·5H2O, 1% Triton X-100, 2 mg / ml BSA, 0.1 mM EDTA, 33.3 mM DTT, 0.05 mM firefly luciferase, and 157 mM D-luciferin potassium salt.

[0052] (2) Prepare component II, which specifically includes: 30 mM Tricine, 2 mM MgSO4, 0.1 mM EDTA, 33.3 mM DTT, and 0.58 mM ADP.

[0053] (3) 21 wells were selected from a black 96-well test plate and divided into 7 groups, with 3 replicates in each group. 50 μl of mycoplasma positive sample was added to each well, and then 50 μl of component A was added to each well. After being placed at 20-25°C for 15 minutes, 50 μl of component B was added to each well. At 0, 5, 10, 15, 20, 25 and 30 minutes, a group was selected and chemiluminescence detection was performed using a multifunctional microplate reader, and the reading value was B. The results are shown in Table 4.

[0054] Table 4. Time gradient fluorescence detection results of component B

[0055] name B1 B2 B3 Mycoplasma positive sample + component I + 15min + component II + 0min 11000 13000 12000 Mycoplasma positive sample + component I + 15min + component II + 5min 21000 20000 21000 Mycoplasma positive sample + component I + 15min + component II + 10min 20000 19000 21000 Mycoplasma positive sample + component I + 15min + component II + 15min 17000 18000 20000 Mycoplasma positive sample + component I + 15min + component II + 20min 13000 15000 15000 Mycoplasma positive sample + component I + 15min + component II + 25min 13000 12000 13000 Mycoplasma positive sample + component I + 15min + component II + 30min 9000 10000 11000

[0056] The results showed that in the case of mycoplasma positive samples, component I and the same reaction time, as the reaction time increased after the addition of component II, the fluorescence excitation intensity first increased and then weakened. At 5 minutes of reaction, the fluorescence excitation intensity was the highest.

[0057] Example 5: Fluorescence detection between different reagent combinations of the kit of the present invention.

[0058] The specific steps include:

[0059] (1) The kits of the present invention with different reagent combinations were prepared, and the specific components are shown in Table 5.

[0060] Table 5. Kits of the present invention with different reagent combinations

[0061]

[0062]

[0063] (2) Add 50 μl of the sample to be tested to each black 96-well test plate, with 3 replicates for each sample. Then add 50 μl of component I to each well, mix well, and place at 20-25°C for 15 minutes. Then use a multifunctional microplate reader to perform chemiluminescence detection, and the reading is A. Then add 50 μl of component II to each well, mix well, and place at 20-25°C for 5 minutes. Then use a multifunctional microplate reader to perform chemiluminescence detection, and the reading is B.

[0064] (3) Determine whether there is mycoplasma contamination by calculating the ratio of B to A. When B / A>1, it indicates that the cells are contaminated with mycoplasma; when B / A<1, it indicates that the cells are not contaminated with mycoplasma; when the value of B / A is within the range of 1±0.1, in order to ensure the accuracy of the results, the cells should be cultured for 48 hours and the experiment should be repeated. The results are shown in the following table.

[0065] Table 6. Results of mycoplasma detection by kit combination 1 of the present invention

[0066] name HepG2 A549 HeLa Hek293T Positive Control Negative control A1 83.627 17.927 23.746 43.822 27.876 62.978 A2 47.492 15.935 33.038 37.846 49.798 46.459 A3 65.323 13.943 33.038 41.833 17.927 40.265 B1 101.38 130.762 14.786 17.135 80.265 22.178 B2 66.535 155.909 11.617 19.111 243.41 26.403 B3 82.903 177.032 11.617 11.064 130.762 15.842 B1 / A1 1.21 7.29 0.62 0.39 2.88 0.35 B2 / A2 1.40 9.78 0.35 0.50 4.88 0.56 B3 / A3 1.27 12.69 0.35 0.26 7.29 0.39

[0067] Table 7. Results of mycoplasma detection by kit combination 2 of the present invention

[0068]

[0069]

[0070] Table 8. Results of mycoplasma detection by kit combination 3 of the present invention

[0071] name HepG2 A549 HeLa Hek293T Positive Control Negative control A1 173.58 267.27 203.13 152.34 125.64 236.76 A2 200.13 213.34 222.75 187.98 137.52 300.43 A3 198.12 302.52 278.86 178.57 168.35 268.39 B1 275.14 756.94 79.301 97.875 262.35 120.41 B2 356.23 685.32 89.003 112.35 289.79 138.67 B3 289.78 690.15 102.64 100.28 276.61 166.75 B1 / A1 1.59 2.83 0.39 0.64 2.09 0.51 B2 / A2 1.78 3.21 0.40 0.60 2.11 0.46 B3 / A3 1.46 2.28 0.37 0.56 1.64 0.62

[0072] Table 9. Results of mycoplasma detection by kit combination 4 of the present invention

[0073] name HepG2 A549 HeLa Hek293T Positive Control Negative control A1 556.27 675.83 602.18 441.35 357.82 460.81 A2 632.15 600.18 721.92 396.75 388.92 441.39 A3 595.32 705.16 678.15 469.31 411.21 499.58 B1 1005.2 1135.7 388.63 135.25 795.62 166.32 B2 1212.3 1308.2 303.20 112.35 838.41 133.89 B3 1158.8 1205.6 298.67 120.19 800.15 151.25 B1 / A1 1.81 1.68 0.64 0.31 2.22 0.36 B2 / A2 1.92 2.18 0.41 0.28 2.16 0.30 B3 / A3 1.95 1.71 0.44 0.26 1.95 0.30

[0074] Table 10. Results of mycoplasma detection by kit combination 5 of the present invention

[0075]

[0076]

[0077] Table 11. Results of mycoplasma detection by kit combination 6 of the present invention

[0078] name HepG2 A549 HeLa Hek293T Positive Control Negative control A1 621.37 789.81 711.51 523.57 439.61 675.53 A2 683.39 729.81 821.14 516.79 498.62 593.05 A3 722.43 802.75 883.61 602.39 577.16 621.89 B1 1372.1 1398.2 606.75 257.32 946.25 375.81 B2 1356.3 1499.2 465.55 362.21 1050.3 257.12 B3 1515.6 1578.6 555.62 315.14 1172.2 307.61 B1 / A1 2.21 1.77 0.85 0.49 2.15 0.56 B2 / A2 1.98 2.05 0.57 0.70 2.11 0.43 B3 / A3 2.10 1.97 0.63 0.52 2.03 0.49

[0079] Table 12. Results of mycoplasma detection by kit combination 7 of the present invention

[0080]

[0081]

[0082] (4) The cells selected in the examples were randomly selected, and it is known whether they are contaminated with mycoplasma. The experimental results are consistent with what is known. Due to the limitations of the article, it is not possible to display all the cell detection results one by one, but this should not be a limitation on the use of the kit of the present invention. The kit of the present invention is suitable for detecting mycoplasma contamination of all cell cultures.

[0083] Example 6: Mycoplasma detection of HepG2 cells cultured for different time periods using the kit of the present invention

[0084] The method and steps used in the kit of the present invention are the same as those in Example 5, and the kit is prepared using combination 4 in Example 5.

[0085] name 6h 12h 24h 48h 72h 96h Positive Control Negative control A 327.49 398.31 420.21 455.38 500.31 560.72 523.57 624.12 B 283.2 296.52 327.33 336.15 423.11 398.67 2206.43 315.68 B / A 0.86 0.74 0.78 0.74 0.85 0.72 4.21 0.51

[0086] From the above results, it can be seen that the test results of the test kit prepared by combination 4 are relatively stable.

[0087] Example 6: Comparative experiment between the kit of the present invention and the kit of Biyuntian Company.

[0088] The method and steps used in the kit of the present invention are the same as those in Example 5, and the kit is prepared using Combination 4 in Example 5. The kit of Biyuntian Company is operated according to the instructions.

[0089] (1) Operation steps of the kit of Biyuntian Company: Add 50μl of test sample, positive control and negative control to the 96-well black test plate; then add 50μl of mycoplasma detection reagent A, mix well, and place at 20-25℃ for 5 minutes. Then use a multifunctional microplate reader to perform chemiluminescence detection, that is, the reading is A; then add 50μl of mycoplasma detection reagent B, mix well, and place at 20-25℃ for 10 minutes. Use a multifunctional microplate reader to perform chemiluminescence detection again, that is, the reading is B. Finally, calculate the ratio (Ratio) = reading B / reading A. A ratio greater than 1.2 indicates mycoplasma contamination, a ratio less than 0.9 indicates no mycoplasma contamination, and a ratio between 0.9-1.2 can continue to culture the original sample for 24-48 hours and then retest.

[0090] (2)The results are shown in the following table.

[0091] Table 13. Results of mycoplasma detection by the kit of the present invention

[0092]

[0093]

[0094] Table 14. Results of Mycoplasma Detection by Bio-Tech Company's Test Kit

[0095] name HepG2 A549 HeLa Hek293T Positive Control Negative control A1 285.31 634.33 860.21 993.11 30.963 37.598 A2 236.65 657.52 922.46 921.17 33.175 66.350 A3 234.44 720.95 958.16 1030.3 35.322 57.503 B1 377.87 2084.1 265.22 320.57 44.829 16.031 B2 373.29 2023.5 297.16 377.28 52.527 20.315 B3 384.74 2257.3 313.45 461.51 62.151 27.086 B1 / A1 1.32 3.29 0.31 0.32 1.45 0.42 B2 / A2 1.57 3.08 0.32 0.41 1.58 0.30 B3 / A3 1.64 3.13 0.33 0.45 1.78 0.47

[0096] (3) The cells selected in the examples were randomly selected and it was known whether they were contaminated by mycoplasma. The experimental results were consistent with what was known.

[0097] The kit of the present invention is simple to operate, convenient and time-saving, does not require large-scale experimental instruments and equipment, is very suitable for operation by personnel without any experimental foundation, and is worthy of popularization and use.

[0098] Although the present invention has been described with reference to exemplary embodiments, it should be understood that the present invention is not limited to the disclosed exemplary embodiments. Various adjustments or changes may be made to the exemplary embodiments of the present specification without departing from the scope or spirit of the present invention. The scope of the claims of the present invention should be based on the broadest interpretation to cover all modifications and equivalent structures and functions.

Claims

1. A method for detecting mycoplasma contamination in a cell culture process, characterized in that: The steps include: (1) Add the sample to be tested into a black 96-well test plate; (2) Add component I and pipette evenly to avoid bubbles. Detect the fluorescence value after 15 minutes and record it as A. (3) Add component II and pipette evenly to avoid bubbles. Detect the fluorescence value after 5 minutes and record it as B. (4) Determine whether there is mycoplasma contamination by calculating the ratio of B to A; when B / A>1, it indicates that the cells are contaminated with mycoplasma; when B / A<1, it indicates that the cells are not contaminated with mycoplasma; when the value of B / A is within the range of 1±0.1, in order to ensure the accuracy of the results, the cells should be cultured for another 48 hours and the experiment should be repeated; The component I and component II constitute a reagent composition; The I component comprises the following components: Tricine 20mM; MgSO4 2.6mM; (MgCO3 )4 Mg(OH)2·5H2O 1.2mM; Firefly luciferase 0.03 mM; D-luciferin potassium salt 157mM; Triton X-100 1.5wt%; BSA 1.5 mg / ml; EDTA 0.1 mM; Dithiothreitol (DTT) or mercaptoethanol 10-50mM; Component II comprises the following components: Tricine 10-50mM; MgSO4 2.6mM; EDTA 0.1 mM; DTT 33.3 mM; ADP 0.58mM.